Glen R B Irving

Summary

Affiliation: University of Leicester
Country: UK

Publications

  1. ncbi Curcumin: the potential for efficacy in gastrointestinal diseases
    Glen R B Irving
    University of Leicester, Department of Cancer Studies, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
    Best Pract Res Clin Gastroenterol 25:519-34. 2011
  2. ncbi Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo
    Lynne M Howells
    Cancer Biomarkers and Prevention Group, Cancer Studies and Molecular Medicine, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, United Kingdom
    Int J Cancer 129:476-86. 2011

Detail Information

Publications2

  1. ncbi Curcumin: the potential for efficacy in gastrointestinal diseases
    Glen R B Irving
    University of Leicester, Department of Cancer Studies, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
    Best Pract Res Clin Gastroenterol 25:519-34. 2011
    ..g. ulcerative colitis). However, for the vast majority of conditions additional early-phase studies are required to justify larger trials determining efficacy...
  2. ncbi Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo
    Lynne M Howells
    Cancer Biomarkers and Prevention Group, Cancer Studies and Molecular Medicine, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, United Kingdom
    Int J Cancer 129:476-86. 2011
    ..In vivo, Meriva greatly enhanced oxaliplatin efficacy, without affecting the mode of action of oxaliplatin. Addition of formulated curcumin to oxaliplatin-based chemotherapy regimens has the potential for clinical benefit...